(NASDAQ: AXNX) Axonics's forecast annual revenue growth rate of 20.03% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.29%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.08%.
Axonics's revenue in 2024 is $366,379,000.On average, 6 Wall Street analysts forecast AXNX's revenue for 2024 to be $22,660,262,467, with the lowest AXNX revenue forecast at $22,416,517,080, and the highest AXNX revenue forecast at $23,206,560,195. On average, 6 Wall Street analysts forecast AXNX's revenue for 2025 to be $27,319,221,692, with the lowest AXNX revenue forecast at $26,812,502,625, and the highest AXNX revenue forecast at $28,107,989,722.
In 2026, AXNX is forecast to generate $32,721,759,909 in revenue, with the lowest revenue forecast at $32,721,759,909 and the highest revenue forecast at $32,721,759,909.